Core Laboratories/$CLB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Ticker
$CLB
Sector
Primary listing
NYSE
Employees
3,300
Headquarters
Website
CLB Metrics
BasicAdvanced
$585M
20.12
$0.62
1.41
$0.04
0.32%
Price and volume
Market cap
$585M
Beta
1.41
52-week high
$21.09
52-week low
$9.72
Average daily volume
511K
Dividend rate
$0.04
Financial strength
Current ratio
2.269
Quick ratio
1.385
Long term debt to equity
62.488
Total debt to equity
66.793
Dividend payout ratio (TTM)
6.33%
Interest coverage (TTM)
4.27%
Profitability
EBITDA (TTM)
62.71
Gross margin (TTM)
19.56%
Net profit margin (TTM)
5.73%
Operating margin (TTM)
9.13%
Effective tax rate (TTM)
29.14%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
4.92%
Return on equity (TTM)
11.78%
Valuation
Price to earnings (TTM)
20.119
Price to revenue (TTM)
1.129
Price to book
2.22
Price to tangible book (TTM)
3.74
Price to free cash flow (TTM)
14.863
Free cash flow yield (TTM)
6.73%
Free cash flow per share (TTM)
0.84
Dividend yield (TTM)
0.32%
Forward dividend yield
0.32%
Growth
Revenue change (TTM)
0.70%
Earnings per share change (TTM)
23.99%
3-year revenue growth (CAGR)
2.58%
10-year revenue growth (CAGR)
-6.11%
3-year earnings per share growth (CAGR)
50.72%
10-year earnings per share growth (CAGR)
-18.06%
10-year dividend per share growth (CAGR)
-32.71%
What the Analysts think about CLB
Analyst ratings (Buy, Hold, Sell) for Core Laboratories stock.
Bulls say / Bears say
Revenue rose 5% sequentially in Q2, fueled by stronger international demand that offset weaker U.S. land operations (Reuters)
Net debt decreased by $9.1 million during the quarter, reducing the debt-to-EBITDA leverage ratio to 1.27x—its lowest in eight years—enhancing the company’s financial flexibility (Reuters)
The median 12-month price target on Wall Street is $13.00, implying about 2.9% upside from the last closing price, suggesting analysts see modest room for share price appreciation (Reuters)
Adjusted EPS for Q2 dropped 14% year-over-year, signaling continued pressure on underlying profitability despite gains from the previous quarter (Reuters)
Management highlighted that geopolitical uncertainties and ongoing weakness in U.S. land activity are likely to dampen near-term demand for the company’s services and products (Reuters)
The average analyst rating is 'hold,' with only one analyst on 'buy,' three on 'hold,' and one on 'sell,' reflecting limited confidence in the stock (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
CLB Financial Performance
Revenues and expenses
CLB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Core Laboratories stock?
Core Laboratories (CLB) has a market cap of $585M as of September 18, 2025.
What is the P/E ratio for Core Laboratories stock?
The price to earnings (P/E) ratio for Core Laboratories (CLB) stock is 20.12 as of September 18, 2025.
Does Core Laboratories stock pay dividends?
Yes, the Core Laboratories (CLB) stock pays dividends to shareholders. As of September 18, 2025, the dividend rate is $0.04 and the yield is 0.32%. Core Laboratories has a payout ratio of 6.33% on a trailing twelve-month basis.
When is the next Core Laboratories dividend payment date?
The next Core Laboratories (CLB) dividend payment date is unconfirmed.
What is the beta indicator for Core Laboratories?
Core Laboratories (CLB) has a beta rating of 1.41. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.